Ticker Symbol: CALT

Calliditas Therapeutics AB - ADR

$16.59 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Country: Sweden Currency: USD Asset Type: ADR CIK:0001795579

Company Profile

Calliditas is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: Kungsbron 1

Website: https://www.calliditas.se/

CEO: Renee J. Aguiar-Lucander

Tags:

Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST

Previous Close: $17.45

Change: -$0.25 ( -1.44%)

Days Range: $17.45 - $18.34

Beta: -

52wk. High: $25.64

52wk. Low: $11.81

Ytd. Change 2.74%

50 Day Moving Average: $17.29

200 Day Moving Average: $19.01

Shares Outstanding: 29790044

Valuation

Market Cap: 52.0B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A